These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37013974)

  • 1. The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders.
    Chambers NE; Millett M; Moehle MS
    Biochem Soc Trans; 2023 Apr; 51(2):691-702. PubMed ID: 37013974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the M
    Moehle MS; Conn PJ
    Mov Disord; 2019 Aug; 34(8):1089-1099. PubMed ID: 31211471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia.
    Nair AG; Castro LRV; El Khoury M; Gorgievski V; Giros B; Tzavara ET; Hellgren-Kotaleski J; Vincent P
    Neuropharmacology; 2019 Mar; 146():74-83. PubMed ID: 30468798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic acetylcholine M
    Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
    Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
    Scarduzio M; Zimmerman CN; Jaunarajs KL; Wang Q; Standaert DG; McMahon LL
    Exp Neurol; 2017 Sep; 295():162-175. PubMed ID: 28587876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies.
    Tzavara ET; Bymaster FP; Davis RJ; Wade MR; Perry KW; Wess J; McKinzie DL; Felder C; Nomikos GG
    FASEB J; 2004 Sep; 18(12):1410-2. PubMed ID: 15231726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.
    Bubser M; Bridges TM; Dencker D; Gould RW; Grannan M; Noetzel MJ; Lamsal A; Niswender CM; Daniels JS; Poslusney MS; Melancon BJ; Tarr JC; Byers FW; Wess J; Duggan ME; Dunlop J; Wood MW; Brandon NJ; Wood MR; Lindsley CW; Conn PJ; Jones CK
    ACS Chem Neurosci; 2014 Oct; 5(10):920-42. PubMed ID: 25137629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the mGlu
    Yohn SE; Foster DJ; Covey DP; Moehle MS; Galbraith J; Garcia-Barrantes PM; Cho HP; Bubser M; Blobaum AL; Joffe ME; Cheer JF; Jones CK; Lindsley CW; Conn PJ
    Mol Psychiatry; 2020 Nov; 25(11):2786-2799. PubMed ID: 30116027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline.
    Dencker D; Wörtwein G; Weikop P; Jeon J; Thomsen M; Sager TN; Mørk A; Woldbye DP; Wess J; Fink-Jensen A
    J Neurosci; 2011 Apr; 31(16):5905-8. PubMed ID: 21508215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.
    Gomeza J; Zhang L; Kostenis E; Felder CC; Bymaster FP; Brodkin J; Shannon H; Xia B; Duttaroy A; Deng CX; Wess J
    Life Sci; 2001 Apr; 68(22-23):2457-66. PubMed ID: 11392613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Selective and High Affinity Radioligand, [
    Qi A; Kling HE; Billard N; Rodriguez AL; Peng L; Dickerson JW; Engers JL; Bender AM; Moehle MS; Lindsley CW; Rook JM; Niswender CM
    Mol Pharmacol; 2023 Nov; 104(5):195-202. PubMed ID: 37595966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine Muscarinic M
    Walker LC; Berizzi AE; Chen NA; Rueda P; Perreau VM; Huckstep K; Srisontiyakul J; Govitrapong P; Xiaojian J; Lindsley CW; Jones CK; Riddy DM; Christopoulos A; Langmead CJ; Lawrence AJ
    Biol Psychiatry; 2020 Dec; 88(12):898-909. PubMed ID: 32331824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of M4 muscarinic receptors on striatal cholinergic interneurons normalizes striatal dopamine release in a mouse model of TOR1A dystonia.
    Downs AM; Donsante Y; Jinnah HA; Hess EJ
    Neurobiol Dis; 2022 Jun; 168():105699. PubMed ID: 35314320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats.
    Brugnoli A; Pisanò CA; Morari M
    Neurobiol Dis; 2020 Oct; 144():105044. PubMed ID: 32798726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice.
    Tzavara ET; Bymaster FP; Felder CC; Wade M; Gomeza J; Wess J; McKinzie DL; Nomikos GG
    Mol Psychiatry; 2003 Jul; 8(7):673-9. PubMed ID: 12874603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic muscarinic M
    Erskine D; Taylor JP; Bakker G; Brown AJH; Tasker T; Nathan PJ
    Drug Discov Today; 2019 Dec; 24(12):2307-2314. PubMed ID: 31499186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased Profile of Xanomeline at the Recombinant Human M
    McDonald JK; van der Westhuizen ET; Pham V; Thompson G; Felder CC; Paul SM; Thal DM; Christopoulos A; Valant C
    ACS Chem Neurosci; 2022 Apr; 13(8):1206-1218. PubMed ID: 35380782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of direct pathway striatal projection neurons by muscarinic M₄-type receptors.
    Hernández-Flores T; Hernández-González O; Pérez-Ramírez MB; Lara-González E; Arias-García MA; Duhne M; Pérez-Burgos A; Prieto GA; Figueroa A; Galarraga E; Bargas J
    Neuropharmacology; 2015 Feb; 89():232-44. PubMed ID: 25290553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt
    Hamann M; Plank J; Richter F; Bode C; Smiljanic S; Creed M; Nobrega JN; Richter A
    Neuroscience; 2017 Aug; 357():84-98. PubMed ID: 28596119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.